Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women

Journal of Infectious Diseases

Volumn 184, Issue 11, 2001, Pages 1412-1422

  Bélec, Laurent ^a,b   Ghys, Peter D ^c   Hocini, Hakim ^a   Nkengasong, John N ^c   Tranchot Diallo, Juliette ^a,b   Diallo, Mamadou O ^c   Ettiégne Traore, Virginie ^c   Maurice, Chantal ^c   Becquart, Pierre ^a   Matta, Mattieu ^b   Si Mohamed, Ali ^b   Chomont, Nicolas ^a,b   Coulibaly, Issa Malick ^c   Wiktor, Stefan Z ^c,d   Kazatchkine, Michel D ^a  

^a INSERM   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c Projet RETRO CI ^*  (France)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RANTES;

ADULT; AFRICA; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; PRIORITY JOURNAL; TRANSCYTOSIS; VAGINA EPITHELIUM;

ADOLESCENT; ADULT; AFRICA; ANTIBODY SPECIFICITY; BIOLOGICAL TRANSPORT; CELL LINE; CERVIX UTERI; CYTOKINES; EPITHELIUM; EPITOPE MAPPING; FEMALE; GENE PRODUCTS, ENV; HIV ANTIBODIES; HIV ANTIGENS; HIV SERONEGATIVITY; HIV-1; HUMANS; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULINS; MIDDLE AGED; PROSTITUTION; VAGINA;

EID: 0035576930     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/324375     Document Type: Article

References (55)

1. Cellular target of infection and route of viral dissemination after intravaginal inoculation of SIV into rhesus macaques
2. Mechanism of HIV spread from lymphocytes to epithelia
3. Transcytosis of infectious hurnan irnmunodeficiency virus across a tight human epithelial cell line barrier
4. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope dIgA or IgM
5. Molecular and cellular basis of immune protection of mucosal surfaces
6. Secretory immunity in the female reproductive tract
7. Antibodies to human immunodeficiency virus in cervical secretions from women at risk for AIDS
8. Antibodies to human immunodeficiency virus in vaginal secretion of heterosexual women
9. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasting with normal or impaired local response in HIV infection
10. High-level ability of secretory IgA to block HIV type I transcytosis: Contrasting secretory IgA and IgG responses to glycoprotein 160
11. HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women
12. + lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi
13. Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques
14. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
15. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1
16. Cytotoxic T-cell response epitopes in HIV-resistant prostitutes in Nairobi
17. Detection of antibodies to human immunodeficiency virus in vaginal secretions by immunoglobulin G antibody capture enzyme-linked immunosorbent assay: Application to detection of seminal antibodies after sexual intercourse
18. HIV-1 antibody serum negativity with vaginal secretion positivity
19. Detection of seminal antibodies to HIV in vaginal secretions after sexual intercourse: A possible tool to prevent the risk of HIV transmission in a rape victim
20. Mucosal and plasma IsA from HIV-1exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells
21. Cervicovaginal anti-HIV antibodies in HIV-seronegative female sex workers in Abidjan Côte d'Ivoire
22. Detection of HIV-specific antibodies in saliva and cervical secretions
23. HIV-1 specific antibodies in cervicovaginal lavage of high risk HIV-1 seronegative women
24. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
25. Human immunodeficiency virus (HIV)-specific IsA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons
26. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers
27. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate
28. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed persistently seronegative female sex workers in northern Thailand
29. The association between cervicovaginal HIV shedding sexually transmitted diseases and immunosuppression in female sex workers in Abidjan Côte d'Ivoire
30. Trends in condom use and sexual behavior between 1991 and 1997 and obstacles to 100% condom use in female sex workers (FSW) in Abidjan Côte d'Ivoire
31. Immune activation markers and chemokine receptor 5 (CCR5) genotype in highly exposed but persistently seronegative female sex workers in Abidjan Côte d'Ivoire
32. Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays
33. Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers
34. An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences: Application to hemophilia
35. Genetically related human immunodeficiency virus type 1 in three adults of a family with no identified risk factor for intrafamilial transmission
36. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic
37. Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 categories) patients with HIV-1 and HIV-2 infection
38. Specific and secretory humoral immunity in the normal human cervicovaginal secretions
39. HIV-enhancing proinflammatory cytokines in cervicovaginal secretions from normal and HIV-infected women
40. Antibody avidity determination by ELISA using thiocyanate elution
41. Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection
42. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
43. Antibodies to human immunodeficiency virus in the seminal fluid of heterosexual men
44. Polymerase chain reaction for Y chromosome to detect semen in cervicovaginal fluid: A prerequisite to assess HIV-specificvaginal immunity and HIV genital shedding
45. Human immunodeficiency virus type 1 and mucosal humoral defense
46. HIV neutralizing IgA in exposed seronegative subjects recognise an epitope within the gp41 coiled-coil pocket
47. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG
48. Compartmentalization of the IgG immune response to HIV-1 in breast milk
49. Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1
50. Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia
51. Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative women
52. Up-regulation of beta-chemokines and down-modulation of CCR5 co-receptors inhibit simian immunodeficiency virus transmission in non-human primates
53. Female genital tract immunity in animal models
54. Challenges for vaccination against sexually-transmitted diseases: Induction and long-term maintenance of mucosal immune responses in the female genital tract
55. Mucosal vaccination strategies for women